×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
The Metamorphosis of Clinical Trials: Evolving Roles of Stakeholders in Digital Trials
Session Chair(s)
Josh Rose, MBA
Chief Executive Officer
Hawthorne Effect, Inc. , United States
This session will examine the promise of virtual trials to address challenges of traditional site-based models by examining the evolving roles of study stakeholders, patients, investigators, and study managers, and how they improve study performance
Learning Objective : Describe the potential promise, benefits, and considerations of virtual clinical trials to address challenges to clinical trial conduct and participation; Define the evolution of stakeholder roles, existing and new, and the interplay between them, in virtual/direct to patient clinical trials; Apply insights to inform virtual trial design and planning.
Speaker(s)
Panelist
Angela Botto-van Bemden, PhD
Musculoskeletal Research International, United States
Director, OA Programs
Panelist
Jeff Kingsley, DO, MBA
IACT Health, United States
Chief Executive Officer
Panelist
Christina Markus, JD
King & Spalding LLP, United States
Partner, FDA and Life Sciences
Panelist
Robert Goldman, PhD
Sunovion, United States
Head of Global Clinical Research & Medical Affairs
Have an account?